Literature DB >> 31112123

Drug Overdose Deaths Involving Fentanyl, 2011-2016.

Merianne R Spencer, Margaret Warner, Brigham A Bastian, James P Trinidad, Holly Hedegaard.   

Abstract

Objectives-Fentanyl, a synthetic opioid, has been increasingly identified in drug overdose deaths. This report describes trends in drug overdose deaths involving fentanyl by demographic characteristics and geographic regions from 2011 through 2016. Methods-Drug overdose deaths were identified from the National Vital Statistics System-Mortality (NVSS-M) multiple cause-of-death files (2011-2016) using International Classification of Diseases, 10th Revision underlying causes of death (codes X40-X44, X60-X64, X85, or Y10-Y14). NVSS-M records for drug overdose deaths were linked with literal text from death certificates. Drug overdose deaths involving fentanyl were identified using a methodology established collaboratively by the National Center for Health Statistics and U.S. Food and Drug Administration-referred to as the Drugs Mentioned with Involvement (DMI) methodology-supplemented with search terms identified using text analytics software. Fentanyl involvement was determined by the presence of any string term or phrase listing fentanyl, or any fentanyl metabolite, precursor, analog, or misspelling identified in the death certificate literal text fields (i.e., the causes of death from Part I, significant conditions contributing to death from Part II, and a description of how the injury occurred). Trends were evaluated using the National Cancer Institute's Joinpoint Regression Program. Results-The number of drug overdose deaths involving fentanyl was stable in 2011 (1,663) and 2012 (1,615), and began to increase in 2013, rising to 18,335 deaths in 2016. The ageadjusted rate increased from 0.5 per 100,000 standard population in 2011 to 5.9 per 100,000 in 2016, with the increase starting in 2013 (0.6 in 2013 to 1.3 in 2014 and 2.6 in 2015). Numbers and rates increased for all sex, age, and racial and ethnic subgroups, and most public health regions. Adjustment for improved drug reporting over the study period did not change the trend patterns observed. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31112123

Source DB:  PubMed          Journal:  Natl Vital Stat Rep        ISSN: 1551-8922


  47 in total

1.  Life Expectancy and Mortality Rates in the United States, 1959-2017.

Authors:  Steven H Woolf; Heidi Schoomaker
Journal:  JAMA       Date:  2019-11-26       Impact factor: 56.272

2.  Implications of Drug Use Disorders on Spine Surgery.

Authors:  Christopher S Ferari; Gennadiy A Katsevman; Patricia Dekeseredy; Cara L Sedney
Journal:  World Neurosurg       Date:  2020-01-08       Impact factor: 2.104

3.  Trends in Intentional and Unintentional Opioid Overdose Deaths in the United States, 2000-2017.

Authors:  Mark Olfson; Lauren M Rossen; Melanie M Wall; Debra Houry; Carlos Blanco
Journal:  JAMA       Date:  2019-12-17       Impact factor: 56.272

4.  The Toxicology Investigators Consortium Case Registry-the 2018 Annual Report.

Authors:  Meghan B Spyres; Lynn A Farrugia; A Min Kang; Diane P Calello; Sharan L Campleman; Anthony Pizon; Timothy Wiegand; Louise Kao; Brad D Riley; Shao Li; Paul M Wax; Jeffery Brent
Journal:  J Med Toxicol       Date:  2019-10-22

5.  Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018.

Authors:  Mary C Figgatt; Anna E Austin; Mary E Cox; Scott Proescholdbell; Stephen W Marshall; Rebecca B Naumann
Journal:  Drug Alcohol Depend       Date:  2021-01-02       Impact factor: 4.492

6.  Effects of 5-HT2A receptor stimulation on economic demand for fentanyl after intermittent and continuous access self-administration in male rats.

Authors:  David Alexander Martin; Utsav Gyawali; Donna J Calu
Journal:  Addict Biol       Date:  2020-05-26       Impact factor: 4.280

7.  Perceived need for drug treatment among African American male drug-using prisoners.

Authors:  Jardin Dogan; Danelle Stevens-Watkins; Joi-Sheree Knighton; Paris Wheeler; Candice Hargons
Journal:  J Subst Abuse Treat       Date:  2020-10-10

8.  Effects of time-based administration of abstinence reinforcement targeting opiate and cocaine use.

Authors:  Forrest Toegel; August F Holtyn; Shrinidhi Subramaniam; Kenneth Silverman
Journal:  J Appl Behav Anal       Date:  2020-04-06

9.  Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs.

Authors:  Ricky N Bluthenthal; Kelsey Simpson; Rachel Carmen Ceasar; Johnathan Zhao; Lynn Wenger; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2020-03-18       Impact factor: 4.492

10.  Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time.

Authors:  Keri N Althoff; Kathryn M Leifheit; Ju Nyeong Park; Aruna Chandran; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2020-09-25       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.